Koers Clearmind Medicine Inc. Canadian Securities Exchange
Aandelen
CMND
CA1850534027
Biotechnologie & Medisch Onderzoek
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 1,78 mln. 2,44 mln. 1,67 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -9 mln. -12,3 mln. -8,42 mln. | Nettowinst (verlies) 2023 | -8 mln. -10,94 mln. -7,48 mln. | EV/omzet 2022 | - |
Nettoliquiditeiten 2022 | 388K 530K 363K | Nettoliquiditeiten 2023 | 5,51 mln. 7,54 mln. 5,16 mln. | EV/omzet 2023 | - |
K/w-verhouding 2022 |
-1,09
x | K/w-verhouding 2023 |
-0,09
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 100% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,51% | 42,75 mld. | |
+49,22% | 41,61 mld. | |
+8,57% | 41,34 mld. | |
-12,36% | 26,59 mld. | |
+8,92% | 25,49 mld. | |
-25,13% | 18,12 mld. | |
+29,17% | 12,24 mld. | |
-3,12% | 11,76 mld. | |
+6,35% | 11 mld. |